GlaxoSmithKline Stock – GlaxoSmithKline : GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist
GlaxoSmithKline Stock - GlaxoSmithKline : GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist GlaxoSmithKline plc today ...